Salus Pharma Report issue

For profit Phase 2
Founded: Mumbai India (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2011
NCT01055847
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Salus Ltd. | Salus Pharma, Inc. | Salus Research Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

autologous angiogenic cell precursors (1 trial)

aztreonam (azactam) (1 trial)

Drugs in Other Trials (2)

acetaminophen (tylenol) (1 trial)

sodium fluoride (18F) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Infections (Phase 2)

Ischemia (Phase 2)

Peripheral Arterial Disease (Phase 2)

Pseudomonas Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4